<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> often develop <z:mp ids='MP_0005048'>thrombosis</z:mp>, <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent abortion</z:e>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological disease</z:e>, in association with serum antibodies against <z:chebi fb="1" ids="16247">phospholipids</z:chebi>, termed the <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In our search for an animal model for the human <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, we examined the MRL-1pr/pr mouse, which develops a <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like illness </plain></SENT>
<SENT sid="2" pm="."><plain>These mice were found to have significantly elevated levels of serum <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> compared to <z:mpath ids='MPATH_458'>normal</z:mpath> mice </plain></SENT>
<SENT sid="3" pm="."><plain>By immunodiffusion, these antibodies are similar to human aPL </plain></SENT>
<SENT sid="4" pm="."><plain>We observed histologic evidence of central <z:mp ids='MP_0008912'>nervous</z:mp> system thromboses as well as perivascular infiltrates of the choroid plexus </plain></SENT>
<SENT sid="5" pm="."><plain>The high titers of serum aPL, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and <z:mp ids='MP_0005048'>thrombosis</z:mp> establish this strain as an animal model for the <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>